Cancer drugs Columvi and Fruzaqla pass first reimbursement hurdle
Cancer drugs Columvi and Fruzaqla have passed the first reimbursement hurdle in South Korea. The Cancer Disease Review Committee has set reimbursement criteria for these drugs, expanding treatment options for certain types of cancer.
HIRA chief urges caution on AI program reimbursement
HIRA chief Kang Jung-gu urged caution on reimbursing AI programs in healthcare, citing the need to consider reduced workloads. He emphasized thorough research before implementing any reimbursement policies for AI in medical settings.
Ministry of Health reviews 36 affiliated agencies' plans
Ministry of Health reviews 2026 work plans of 36 affiliated agencies, focusing on improving infectious disease response, healthcare system transformation, and fostering the biohealth industry.
JPMorgan: Crypto Market Structure Act likely to pass mid-year
JPMorgan predicts the Crypto Market Structure Act will likely pass by mid-2026, potentially transforming the crypto market and attracting institutional investors.